Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Eur J Cardiothorac Surg. 2021 Apr 29;59(4):732-740. doi: 10.1093/ejcts/ezaa426.
Minimally invasive thoracic surgery has evolved with the introduction of robotic platforms. This study aimed to compare the long-term and short-term outcomes of the robot-assisted thoracic surgery (RATS) and video-assisted thoracic surgery (VATS) for anatomic lung resection.
We searched published studies that investigated RATS and VATS in anatomic lung resection. Long-term outcomes (disease-free survival and overall survival) and short-term outcomes (30-day mortality, postoperative complications, conversion rate to open surgery and lymph node upstaging) were extracted. The features were compared and tested as hazard ratios (HRs) and odds ratios (ORs) at a 95% confidence interval (CI).
Twenty-five studies with 50 404 patients (7135 for RATS and 43 269 for VATS) were included. The RATS group had a longer disease-free survival than the VATS group (HR: 0.76; 95% CI: 0.59-0.97; P = 0.03), and the overall survival showed a similar trend but was not statistically significant (HR: 0.77; 95% CI: 0.57-1.05; P = 0.10). The RATS group showed a significantly lower 30-day mortality (OR: 0.55; 95% CI: 0.38-0.81; P = 0.002). No significant difference was found in postoperative complications (OR: 1.01; 95% CI: 0.87-1.16; P = 0.94), the conversion rate to open surgery (OR: 0.92; 95% CI: 0.56-1.52; P = 0.75) and lymph node upstaging (OR: 0.89; 95% CI: 0.52-1.54; P = 0.68).
RATS has comparable short-term outcomes and potential long-term survival benefits for anatomic lung resection compared with VATS.
微创胸外科技术随着机器人平台的引入而发展。本研究旨在比较机器人辅助胸腔镜手术(RATS)和电视辅助胸腔镜手术(VATS)在解剖性肺切除中的长期和短期结果。
我们检索了关于 RATS 和 VATS 解剖性肺切除的已发表研究。提取长期结果(无病生存率和总生存率)和短期结果(30 天死亡率、术后并发症、转为开放性手术的比率和淋巴结分期升级)。使用 95%置信区间(CI)的风险比(HRs)和优势比(ORs)对特征进行比较和检验。
纳入 25 项研究,共 50404 例患者(RATS 组 7135 例,VATS 组 43269 例)。RATS 组的无病生存率长于 VATS 组(HR:0.76;95%CI:0.59-0.97;P=0.03),总生存率也呈现相似趋势,但无统计学意义(HR:0.77;95%CI:0.57-1.05;P=0.10)。RATS 组 30 天死亡率显著降低(OR:0.55;95%CI:0.38-0.81;P=0.002)。术后并发症(OR:1.01;95%CI:0.87-1.16;P=0.94)、转为开放性手术的比率(OR:0.92;95%CI:0.56-1.52;P=0.75)和淋巴结分期升级(OR:0.89;95%CI:0.52-1.54;P=0.68)无显著差异。
与 VATS 相比,RATS 具有相当的短期结果和潜在的长期生存获益,适用于解剖性肺切除术。